These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8738464)

  • 21. [The corneal allograft rejection features in CD4 and CD8 knock-out mice].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):350-4. PubMed ID: 15924699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of 1alpha, 25-dihydroxyvitamin D3 on the acute immune rejection and corneal neovascularization in high-risk penetrating keratoplasty in rats].
    Dang ST; Lu XH; Zhou J; Bai L
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):892-6, 903. PubMed ID: 15321754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats.
    Slegers TP; Torres PF; Broersma L; van Rooijen N; van Rij G; van der Gaag R
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2239-47. PubMed ID: 10892868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
    Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
    Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systemic immunosuppressives after penetrating keratoplasty].
    Reis A; Birnbaum F; Reinhard T
    Ophthalmologe; 2007 May; 104(5):373-80. PubMed ID: 17387480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection.
    Wang M; Lin Y; Chen J; Liu Y; Xie H; Ye C
    Yan Ke Xue Bao; 2002 Sep; 18(3):160-4. PubMed ID: 15510746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term results of FK 506 eye drops following corneal transplantation].
    Reis A; Mayweg S; Birnbaum F; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):57-61. PubMed ID: 18236371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in orthotopic murine corneal transplantation rejection rate with anterior synechiae.
    Yamagami S; Tsuru T
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2422-6. PubMed ID: 10476812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
    Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus immunosuppression in high-risk corneal grafts.
    Joseph A; Raj D; Shanmuganathan V; Powell RJ; Dua HS
    Br J Ophthalmol; 2007 Jan; 91(1):51-5. PubMed ID: 16956911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
    Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
    Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune mechanisms of corneal allograft rejection.
    Niederkorn JY
    Curr Eye Res; 2007 Dec; 32(12):1005-16. PubMed ID: 18085464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W; Pan Z; Zhai C
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation].
    Chen J; Zhou Q; Zeng J; Xu JT; Zhao SB; Wang YP
    Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):550-4. PubMed ID: 14766087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.